Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endologix Inc (NASDAQ:ELGX)

12.65
Delayed Data
As of Sep 01
 -0.33 / -2.54%
Today’s Change
10.29
Today|||52-Week Range
18.07
-17.27%
Year-to-Date
No recent news for Endologix Inc.

Today’s Trading

Previous close12.98
Today’s open12.75
Day’s range12.60 - 12.96
Volume565,607
Average volume (3 months)826,932
Market cap$879.8M
Dividend yield--
Data as of 09/01/2015

Growth & Valuation

Earnings growth (last year)-92.31%
Earnings growth (this year)-59.65%
Earnings growth (next 5 years)+95.60%
Revenue growth (last year)+11.59%
P/E ratioNM
Price/Sales6.76
Price/Book7.02

Competitors

 Today’s
change
Today’s
% change
VSIVitamin Shoppe Inc-1.14-3.18%
LJPCLa Jolla Pharmaceuti...-0.82-2.30%
GBTGlobal Blood Therape...-0.34-0.69%
CYTKCytokinetics Inc-0.06-0.87%
Data as of 09/01/2015

Financials

Next reporting dateOctober 28, 2015
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$147.6M
Annual profit (last year)-$32.4M
Net profit margin-21.97%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
John D. McDermott
President
Robert D. Mitchell
Corporate headquarters
Irvine, California

Forecasts

Partner Offers